| 產(chǎn)品名稱 |
貨號(hào) |
規(guī)格 |
| Recombinant Human Leukemia inhibitory factor receptor (LIFR), partial (Active) |
CSB-MP012929HUi9 |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Tumor necrosis factor ligand superfamily member 13B (TNFSF13B), partial,Biotinylated (Active) |
CSB-MP897523HU1-B |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S), partial |
CSB-YP3324GMY2 |
1mg(1mg*1 or 500ug*2)/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Spike glycoprotein (S) (E484K), partial (Active) |
CSB-MP3324GMY1(M8)h8 |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Mouse Semaphorin-4D (Sema4d), partial (Active) |
CSB-MP020990MO |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Leukemia inhibitory factor (LIF) (Active) |
CSB-MP012928HUd9 |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Semaphorin-4D (SEMA4D), partial (Active) |
CSB-MP835707HU |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Mouse GDNF family receptor alpha-like (Gfral), partial (Active) |
CSB-MP750964MO1 |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Macaca fascicularis Delta-like protein 3 (DLL3), partial (Active) |
CSB-MP3536MOV |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Cystine/glutamate transporter (SLC7A11) (Active) |
CSB-CF892171HU(A4) |
100ug/20ug |
| Recombinant Human Glypican-3 (GPC3) (G537R), partial (Active) |
CSB-MP009705HU(M) |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Delta-like protein 3 (DLL3), partial (Active) |
CSB-MP882142HU |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Semaphorin-4D (SEMA4D), partial (Active) |
CSB-MP835707HUd9 |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Heat-stable enterotoxin receptor (GUCY2C), partial (Active) |
CSB-MP010053HUd9 |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Neuropilin-1 (NRP1) (Active) |
CSB-MP016091HU |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Human Claudin-18.2 (CLDN18.2)-VLPs (Active) |
CSB-MP005498HU(A5) |
1mg(1mg*1 or 500ug*2)/100ug/20ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (T205I) (Active) |
CSB-EP3325GMY(M2) |
1mg(1mg*1 or 500ug*2)/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (P80R) (Active) |
CSB-EP3325GMY(M3) |
1mg(1mg*1 or 500ug*2)/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (P13L) (Active) |
CSB-EP3325GMY(M4) |
1mg(1mg*1 or 500ug*2)/100ug |
| Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (D103Y) (Active) |
CSB-EP3325GMY(M5) |
1mg(1mg*1 or 500ug*2)/100ug |
X 
